Search results
Results from the WOW.Com Content Network
The test was once part of the World Health Organization (WHO) algorithm for diagnosis of dengue fever, [3] however it is no longer used in the latest WHO guidance. [4] Studies have shown that the tourniquet test has low predictive value for dengue fever and should be used in conjunction with other tests for a reliable diagnosis. [5] [6] [7] [8]
The Hess test or Rumpel-Leede test is a medical test used to assess capillary fragility. [1] It is also called the Tourniquet test . To perform the test, pressure is applied to the forearm with a blood pressure cuff inflated to between systolic and diastolic blood pressure for 10 minutes.
In 2003, Children's began an $80 million, 160,000-square-foot (15,000 m 2) clinical expansion and started renovating 100,000 square feet (9,300 m 2) of existing space. Children's became the first freestanding children's hospital in Ohio to receive “Magnet Recognition” in 2004, which is the highest honor for excellence in nursing. [23]
Ohio State, Nationwide Children's proton therapy center brings cancer treatment closer to home. Gannett. Sheridan Hendrix, Columbus Dispatch. December 21, 2023 at 12:28 PM.
In the 1990s, Dr. Christopher Walker led a nationwide project on hepatitis C infection and immunobiology. In 2000, Dr. Robert Castile patented breakthrough technology, an "adult-type" infant pulmonary function testing device. In 2003, the research institute conducted HIV vaccine trials.
Other children then became victims to the new symptom. [4] Epidemic dengue has become more common since the 1980s. By the late 1990s, dengue was the most important mosquito-borne disease affecting humans after malaria, with around 40 million cases of dengue fever and several hundred thousand cases of dengue hemorrhagic fever each year ...
In December 2018, Dengvaxia was approved in the European Union. [7]In May 2019, Dengvaxia was approved in the United States as the first vaccine approved for the prevention of dengue disease caused by all dengue virus serotypes (1, 2, 3, and 4) in people ages nine through 16 who have laboratory-confirmed previous dengue infection and who live in endemic areas.
NS1 antigen test (nonstructural protein 1) is a test for dengue, introduced in 2006. It allows rapid detection on the first day of fever, before antibodies appear some 5 or more days later. [1] It has been adopted for use in some 40 nations. The method of detection is through enzyme-linked immunosorbent assay.